NASDAQ:CGEN

Compugen Stock Insider Trading

etoro logo Buy CGEN
*Your capital is at risk
$2.19
-0.0700 (-3.10%)
At Close: Jun 03, 2026

Compugen Stock Insider Power

Based on the 96 latest insides trades, we have calculated the insider power to be positive at 86.16. In total, the insiders bought 1.6M and sold 46K CGEN shares in the last 96 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 96 transactions)
86.16
Buy 1.6M shares
Sell 46K shares
90% Buy Activity
Moderate Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Apr 01, 2026
Sell
Ordinary Shares
S-Sale
Ophir Eran
President And CEO
CEO / President 5 625
Value: $12.4K
Apr 01, 2026
Buy
Ordinary Shares
M-Exempt
Ophir Eran
President And CEO
CEO / President 5 625
Value: $5K
Apr 01, 2026
Buy
Share Option (right to buy)
M-Exempt
Ophir Eran
President And CEO
CEO / President 5 625
Value: $5K
Apr 01, 2026
Buy
Share Option (right to buy)
M-Exempt
Levine Zurit
SVP, Business Development
Officer 2 500
Value: $2K
Apr 01, 2026
Sell
Ordinary Shares
S-Sale
Levine Zurit
SVP, Business Development
Officer 3 500
Value: $8K
Apr 01, 2026
Buy
Ordinary Shares
M-Exempt
Levine Zurit
SVP, Business Development
Officer 2 500
Value: $2K
Apr 01, 2026
Buy
Ordinary Shares
M-Exempt
Levine Zurit
SVP, Business Development
Officer 1 000
Value: $1K
Apr 01, 2026
Buy
Share Option (right to buy)
M-Exempt
Levine Zurit
SVP, Business Development
Officer 1 000
Value: $1K
Mar 26, 2026
Buy
Share Option (right to buy)
M-Exempt
Levine Zurit
SVP, Business Development
Officer 11 875
Value: $10K
Mar 26, 2026
Sell
Ordinary Shares
S-Sale
Levine Zurit
SVP, Business Development
Officer 11 875
Value: $24.2K
Mar 26, 2026
Buy
Ordinary Shares
M-Exempt
Levine Zurit
SVP, Business Development
Officer 11 875
Value: $10K
Mar 18, 2026
Buy
Share Option (right to buy)
Ophir Eran
President And CEO
CEO / President 60 000
Value: $194.4K
Mar 18, 2026
Buy
Share Option (right to buy)
Ophir Eran
President And CEO
CEO / President 30 000
Value: $24.9K
Mar 18, 2026
Buy
Share Option (right to buy)
Ophir Eran
President And CEO
CEO / President 65 000
Value: $74.8K
Mar 18, 2026
Buy
Share Option (right to buy)
Ophir Eran
President And CEO
CEO / President 42 250
Value: $71.4K
Mar 18, 2026
Buy
Share Option (right to buy)
Ophir Eran
President And CEO
CEO / President 65 000
Value: $94.9K
Mar 18, 2026
Buy
Share Option (right to buy)
Ophir Eran
President And CEO
CEO / President 135 000
Value: $186.3K
Mar 18, 2026
Buy
Ordinary Shares
Mahler Michelle
Chief Medical Officer
Officer 0
Value: $0
Mar 18, 2026
Buy
Share Option (right to buy)
Mahler Michelle
Chief Medical Officer
Officer 40 000
Value: $35.2K
Mar 18, 2026
Buy
Share Option (right to buy)
Mahler Michelle
Chief Medical Officer
Officer 35 750
Value: $60.4K
Mar 18, 2026
Buy
Share Option (right to buy)
Mahler Michelle
Chief Medical Officer
Officer 18 000
Value: $26.3K
Mar 18, 2026
Buy
Ordinary Shares
Levine Zurit
SVP, Business Development
Officer 0
Value: $0
Mar 18, 2026
Buy
Share Option (right to buy)
Levine Zurit
SVP, Business Development
Officer 42 000
Value: $279.3K
Mar 18, 2026
Buy
Ordinary Shares
Zweifach Sanford S
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Share Option (right to buy)
Levine Zurit
SVP, Business Development
Officer 42 000
Value: $132.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT COMPUGEN LTD.
Compugen
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE